Stryker Corporation Plans Quarterly Dividend of $0.88 (NYSE:SYK)

Key Points

• Stryker declared a quarterly dividend of $0.88 per share, payable October 30 to shareholders of record September 30. The dividend implies an annualized payout of $3.52 and a yield of approximately 1.0%.
• The company has increased its dividend for 32 consecutive years, while its 23.7% payout ratio indicates the dividend remains well covered by earnings.
• Stryker recently exceeded quarterly earnings expectations, reporting $3.69 in EPS on $6.59 billion in revenue, with revenue up 9.4% year over year.

Stryker Corporation (NYSE:SYK - Get Free Report) declared a quarterly dividend on Tuesday, August 4th. Investors of record on Wednesday, September 30th will be given a dividend of 0.88 per share by the medical technology company on Friday, October 30th. This represents a c) dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, September 30th.

Stryker has raised its dividend by an average of 0.1%annually over the last three years and has raised its dividend every year for the last 32 years. Stryker has a dividend payout ratio of 23.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Stryker to earn $16.75 per share next year, which means the company should continue to be able to cover its $3.52 annual dividend with an expected future payout ratio of 21.0%.

Stryker Trading Up 0.2%

NYSE:SYK opened at $337.69 on Thursday. Stryker has a one year low of $281.00 and a one year high of $396.86. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The firm has a market capitalization of $129.53 billion, a price-to-earnings ratio of 35.20, a price-to-earnings-growth ratio of 2.14 and a beta of 0.76. The business has a fifty day moving average price of $318.85 and a 200-day moving average price of $334.29.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker's revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts forecast that Stryker will post 15.02 EPS for the current year.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source